Discovery of low-molecular-weight ligands for the AF6 PDZ domain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Angewandte Chemie

• Publication date

  2006-06-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/ANIE.200503965PMID 16671149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.

  2004cited by this paper
• The Bcr Kinase Downregulates Ras Signaling by Phosphorylating AF-6 and Binding to Its PDZ Domain

  2003cited by this paper
• Novel Mode of Ligand Recognition by the Erbin PDZ Domain*

  2003cited by this paper
• Assembly of Cell Regulatory Systems Through Protein Interaction Domains

  2003cited by this paper
• Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.

  2002cited by this paper
• Mechanism and role of PDZ domains in signaling complex assembly.

  2001cited by this paper
• Multidimensional NMR Methods for Protein Structure Determination

  2001cited by this paper
• Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1.

  2000cited by this paper
• Nectin/PRR: An Immunoglobulin-like Cell Adhesion Molecule Recruited to Cadherin-based Adherens Junctions through Interaction with Afadin, a PDZ Domain–containing Protein

  1999cited by this paper
• The Junction-associated Protein AF-6 Interacts and Clusters with Specific Eph Receptor Tyrosine Kinases at Specialized Sites of Cell–Cell Contact in the Brain

  1999cited by this paper
• Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex.

  1999cited by this paper
• Protein backbone angle restraints from searching a database for chemical shift and sequence homology

  1999cited by this paper
• PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.

  1998cited by this paper
• Journal speciation

  1998cited by this paper
• Torsion angle dynamics for NMR structure calculation with the new program DYANA.

  1997cited by this paper
• PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences

  1997cited by this paper
• Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains

  1997cited by this paper
• AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR

  1996cited by this paper
• Crystal structure of a PDZ domain

  1996cited by this paper
• Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ.

  1996cited by this paper
• MOLMOL: a program for display and analysis of macromolecular structures.

  1996cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation.

  1993cited by this paper
• Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid.

  1985cited by this paper

• Multivalent interactions make adherens junction–cytoskeletal linkage robust during morphogenesis

  2021cites this paper
• Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.

  2021cites this paper
• Identification of Novel Fragments Binding to the PDZ1‐2 Domain of PSD‐95

  2020cites this paper
• Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease.

  2019cites this paper
• Highly enantioselective addition of sulfur-containing heterocycles to isatin-derived ketimines.

  2019cites this paper
• Skeletal rearrangement of arylmethylideneimidazo[4,5-e]thiazolo[3,2-b]-1,2,4-triazine-2,7-diones in the synthesis of the corresponding imidazo[4,5-e]thiazolo[2,3-c]-1,2,4-triazine-2,8-diones

  2019cites this paper
• Emerging Themes in PDZ Domain Signaling

  2018cites this paper
• Catalyst-free synthesis of thiazolidines via sequential hydrolysis/rearrangement reactions of 5-arylidenethiazolidin-4-ones at room temperature.

  2018cites this paper
• Lock and chop: A novel method for the generation of a PICK1 PDZ domain and piperidine‐based inhibitor co‐crystal structure

  2018cites this paper
• Protein–Protein Interaction Inhibitors in Cancer

  2017cites this paper
• [Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity

  2016cites this paper
• Dégradation de protéines ciblées destinée à atténuer une thérapie par transfert adoptif de cellules t associée des réponses inflammatoires indésirables

  2016cites this paper
• The Chlamydia trachomatis Protease CPAF Contains a Cryptic PDZ-Like Domain with Similarity to Human Cell Polarity and Tight Junction PDZ-Containing Proteins

  2016cites this paper
• Targeting Virulence as an Approach to Bacterial Pathogenesis: Efforts Towards the Development of Chemical Biology Tools and Anti-Chlamydial Therapeutics

  2016cites this paper
• State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.

  2015cites this paper
• Crystal structure of afadin PDZ domain–nectin‐3 complex shows the structural plasticity of the ligand‐binding site

  2015cites this paper
• An efficient and green procedure for synthesis of rhodanine derivatives by aldol-thia-Michael protocol using aqueous diethylamine medium

  2014cites this paper
• Small‐Molecule Inhibitors of AF6 PDZ‐Mediated Protein–Protein Interactions

  2014cites this paper
• 1 Ligand binding by PDZ domains

  2014influential citation
• “On water” catalyst-free, column chromatography-free and atom economical protocol for highly diastereoselective synthesis of novel class of 3-substituted, 3-hydroxy-2-oxindole scaffolds at room temperature

  2014cites this paper
• Interactions of native peptides and small molecules with the PDZ domains of PSD-95 and SAP97

  2013cites this paper
• Nuclear Magnetic Resonance Methods for Studying Soluble, Fibrous, and Membrane-Embedded Proteins

  2013cites this paper
• Asymmetric Michael addition of substituted rhodanines to α,β-unsaturated ketones catalyzed by bulky primary amines.

  2012cites this paper
• The schizophrenic faces of PICK 1

  2012cites this paper
• Ligand binding by PDZ domains

  2012cites this paper
• Using fragment-based technologies to target protein-protein interactions.

  2012cites this paper
• An uncatalyzed aldol reaction of thiazolidinediones

  2012cites this paper
• Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry.

  2012cites this paper
• Studying protein-protein interactions using peptide arrays.

  2011cites this paper
• A fluorescence polarization based screening assay for identification of small molecule inhibitors of the PICK1 PDZ domain.

  2011cites this paper
• Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.

  2010cites this paper
• Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1.

  2010cites this paper
• Design, synthesis, structure and binding properties of PDZ binding, cyclic beta-finger peptides.

  2010cites this paper
• Protein-Protein Interactions: Recent Progress in the Development of Selective PDZ Inhibitors

  2009cites this paper
• Synthesis and Application of Peptide Arrays: Quo Vadis SPOT Technology

  2009cites this paper
• Optimizing Dvl PDZ domain inhibitor by exploring chemical space

  2009cites this paper
• Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD

  2009cites this paper
• Therapeutic use of PDZ protein-protein interaction antagonism.

  2008cites this paper
• Immunoassays: biological tools for high throughput screening and characterisation of combinatorial libraries.

  2008cites this paper
• Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.

  2008cites this paper
• Bivalent Peptides as Models for Multimeric Targets of PDZ Domains

  2007cites this paper
• Characterization of a Putative Phosphorylation Switch: Adaptation of SPOT Synthesis to Analyze PDZ Domain Regulation Mechanisms

  2007cites this paper
• Practical aspects of NMR-based fragment discovery.

  2007cites this paper
• Fragment Screening: Biochemical Assays Versus NMR The identification of fragment starting points is a key challenge

  2007cites this paper
• High-Throughput Screen for Small Molecule Inhibitors of Mint1-PDZ Domains

  2007cites this paper
• Novel Disease Targets Are the Life-blood of the Biotech and Pharmaceutical Industries. However, of Equal Fragment Screening: Biochemical Assays versus Nmr

  2007cites this paper
• Beta strand peptidomimetics as potent PDZ domain ligands.

  2006cites this paper
• The schizophrenic faces of PICK1.

  2006cites this paper
• Modulateurs du domaine pdz

  2006cites this paper
• Brief Communication b Strand Peptidomimetics as Potent PDZ Domain Ligands

  2006cites this paper
• β Strand Peptidomimetics as Potent PDZ Domain Ligands

  2006cites this paper